Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy uses certain drugs to try to prevent the development or
recurrence of cancer. Celecoxib may be effective in preventing the development or recurrence
of lung cancer in former heavy smokers.
PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing the
development or recurrence of lung cancer in former heavy smokers who are at risk of
developing cancer.